Mécanismes d'action antivirale de l'interféron

Virologie

Volumn 1, Issue 6, 1997, Pages 481-497

  Meurs, E F ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001658420     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Isaacs A, Lindenmann J. Virus interference. 1. The interferon. Proc Roy Soc London B Biol Sci 1997 ; 147 : 258-67.
2. Roberts RM, Cross JC, Leaman DW. Interferons as hormones of pregnancy. Endocr Rev 1992 ; 13 : 432-52.
3. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996 ; 383 : 787-93.
4. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2 regulators of cell growth and the interferon system. Moll Cell Biol 1993 ; B : 4531-8.
5. Reis LFL, Harada H, Wolchok JD, Taniguchi T, Vilcek J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J 1992 ; 11 : 185-93.
6. Reis LFL, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 1994 ; 13 : 4798-806.
7. Kirchhoff S, Koromilas A, Schaper F, Grashoff M, Sonenberg N, Hauser H. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 1995 ; 11 : 439-45.
8. Tamura T, Ishihara M, Lamphier MS, et al An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes Nature 1995 ; 376 : 596-9.
9. Uze G, Lutfala G, Gresser I Genetic transfer of a functional human interferon a receptor into mouse cells : cloning and expression of its cDNA. Cell 1990 ; 60 : 225-34.
10. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994 ; 77 : 391-400.
11. Farrar MA, Schreiber RD. The molecular cell biology of interferon-gamma and its receptor. [Review] Ann Rev Immunol 1993 ; 11 : 571-611.
12. Bach EA, Tanner JW, Marsters S, et al. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 1996 ; 16 : 3214-21.
13. Levy DE. Interferon induction of gene expression through the Jak-Stat pathway. Semin Virol 1995 ; 6 : 181-9.
14. Sen GC, Ransohoff RM. Interferon-induced antiviral actions and their regulations. Adv Vir Res 1993 ; 42 : 57-102.
15. Pavlovic J, Schroder A, Blank A, Pitossi F, Staeheli P. Mx proteins : GTPases involved in the interferon-induced antiviral state (Review). Ciba Foundation Symposium 1993 , 176 . 233-47.
16. Horisberger MA. Interferons. Mx genes, and resistance to influenza virus [Review] Am J Res Crit Care Med 1995 ; 152 : S67-71.
17. Zhou A, Hassel BA, Silverman RH. Expression cloning of a 2-5A-dependent Rnase : a uniquely regulated mediator of interferon action. Cell 1993 ; 72 : 753-65.
18. Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T, Cloning and characterization of a Rnase L inhibitor. J Biol Chem 1995 ; 270 : 13308-37
19. Muller WEG, Weiler BE, Charubala R, et al. Cordycepin analogues of 2′,5′-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry 1991 ; 30 . 2027-33.
20. Castora FJ, Erickson CE, Kovacs T, Lesiak K, Torrence PF. 2′,5′-oligoadenylate inhibits relaxation of supercoiled DNA by calf thymus DNA topoisomerase I. J Interferon Res 1991 ; 11 : 143-9
21. Chebath J, Benech P, Revel M, Vigneron M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 1987 ; 330 : 587-8.
22. Marié I, Hovanessian AG. The 69-Kd 2-5A synthetase is composed of two homologous and adjacent functional domains. J Biol Chem 1992 ; 267 : 9933-9.
23. Sen GC, Lengyel P. The interferon system. A bird's eye view of its biochemistry (Review). J Biol Chem 1992 ; 267 : 5017-20.
24. Coccia EM, Romeo G, Nissim A, et al. A full-length murine 2-5A synthetase cDNA transfected in NIH3T3 cells impairs EMCV but no VSV replication. Virology 1990 ; 179 : 228-33.
25. + cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2′,5′-oligoadenylate synthetase hybrid gene. The FASEB J 1990 ; 4 : 3124-30.
26. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, Mac Micking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993 ; 10 : 1445-8.
27. Melkova Z, Esteban M. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J Immunol 1995 ; 155 : 5711-8.
28. Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ. An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J Biol Chem 1997 ; 272 : 1226-30.
29. Fruh K, Gossen M, Wang K, Bujard H, Peterseon PA, Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs : a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 1994 ; 13 : 3236-44.
30. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990 ; 347 : 558-61.
31. Stadler M, Chelbi-Alix MK, Koken HM. et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and GAS element. Oncogens 1995 ; 11 : 2565-73.
32. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS. PML. a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 1994 ; 14 : 6858-67.
33. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 1997 ; 16 : 566-77.
34. Lavau C, Marchio A, Fagioli M. et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 1995 ; 11 : 871-6.
35. Loeb KR, Haas AL. The interferon-inducible 15 kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 1992 ; 267 : 7806-13.
36. Narasimhan J, Potter JL, Haas AL. Conjugation of the 15 kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J Biol Chem 1996 ; 271 : 324-30.
37. Recht M, Borden EC, Knight E. A human 15 kDa IFNi-induced protein induces the secretion of IFN-γ. J Immunol 1991 ; 147 : 2617-23.
38. Hovanessian AG, Kerr IM. The (2′5′) oligoadenylate (pppA2′-5′A2′-5′A) synthetase and protein kinase(s) from interferon-treated cells. Eur J Biothem 1991 ; 93 : 515-26.
39. Meurs EF, Chong K, Galabru, et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990 ; 62 : 379-90
40. McCormack SJ, Thomis DC, Samuel CE. Mechanism of interferon action . Identification of a RNA binding domain within the N-terminal region of the RNA-dependent Pl/eIF-2a protein kinase. Virology 1992 ; 188 : 47-56.
41. Bycroft M, Grunert S, Murzin AG, Proctor M. St Johnston D NLR solution structure of a dsRNA binding domain from Drosophila staufen protein S5. EMBO J 1995 ; 14 : 3563-71.
42. Schmedt C, Green SR, Manche L, Tavlor DR, Ma Y, Mathews MB. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J Mol Biol 1995 ; 249 : 29-44
43. Hovanessian AG. Interferon-induced dsRNA activated protein kinase (PKR) : antiproliferative. antiviral and antitumoral functions. Seminars Virol 1993 ; 4 : 237-45.
44. Desai SY, Patel RC, Sen GC, Malhotra P, Ghadge CD, Thimmapaya B. Activation of interferon-mducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J Biol Chem 1995 ; 270 : 3454-61.
45. Romano PR, Green SR, Barber GN, Mathew MB, Hinnebusch AG. Structural requirements for double-stranded RNA binding, dimerization. and activation of the human eIF-2a kinase DAI in Saccharomyces cerevisiae. Mol Cell Biol 1995 ; 15 : 365-78.
46. Williams BRG. The role of the dsRNA-activated protein kinase. PKR, in signal transduction. Sem Virol 1995 ; 6 : 191-202.
47. Proud CG PKR : a new name and new roles. TIBS 1995 ; 20 : 241-6.
48. Chong KL, Schappert K, Meurs E, et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2, EMBO J 1992 ; 11 : 1553-62.
49. Craig AWB, Cosentino GP, Donzé O, Sonenberg N. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J Biol Chem 1996 ; 271 : 24526-33.
50. Hershey. Translational control in mammalian cells. Annu Rev Biochem 1991 ; 60 : 717-55.
51. Meurs EF, Watanabe Y, Kadereit S. et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis growth. J Virol 1992 ; 66 : 5805-14.
52. Jeffrey IW, Kadereit S, Meurs EF. et al. Nuclear localization of the interferon-induced protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 1995 ; 218 : 17-27.
53. Kadereit S, Gewert D, Hovanessian AG, Meurs EF. Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J Biol Chem 1993 ; 268 : 24432-41.
54. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase Science 1992 ; 257 : 1685-9.
55. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. Tumor suppressor function of the interferon-induced. double-stranded RNA-activated 68,000-Mr protein kinase. Proc Natl Acad Sci (USA) 1993 ; 90 : 232-6.
56. Donzé O, Jagus R, Koromilas AE, Hershey JWB, Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995 ; 14 : 3828-34.
57. Barber GN, Jagus R, Meurs EF, Hovanessian AG, Katze MG. Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase J Biol Chem 1995 ; 270 : 17423-8.
58. Lee B, Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 1994 ; 199 : 491-6.
59. Takizawa T, Ohashi K, Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol 1996 ; 70 : 8128-32.
60. Yang YL, Reis LFL, Pavlovic J. et al. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 1995 ; 14 : 6095-106.
61. Kumar A, Yang YL, Flati V, et al. Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene : role of IRF-1 and NF-κB. EMBO J 1997 ; 16 : 406-16.
62. Meurs EF, McMillan N, Williams BRG, Hovanessian AG, Southern P. Human PKR transfected into murine cells stimulates expression of genes under control of HIV1 and HTLV1 LTR. Virology 1995 ; 214 : 653-9.
63. Gale M, Tan SL, Wambach M, Katze M. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and Vaccinia Virus K3L is mediated by unique domains ; implications for kinase regulation. Mol Cell Biol 1996 ; 16 : 4172-81
64. Xiao Q, Sharp TV, Jeffrey IW, et al. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res 1994 ; 22 : 2512-8.
65. Gatignol A, Buckler C, Jeang KT. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila Staufen. Mol Cell Biol 1993 ; 13 : 2193-202.
66. Benkirane M, Neuvent C, Chun RF, et al. Oncogenic potential of TAR RXA-binding TRBP and its regulatory interaction with protein kinase R. EMBO J 1997 ; 16 : 611-24.
67. Lane HC. Interferons in HIV and related diseases. AIDS 1994 ; 8 : s19-s23.
68. Pollard RB. Use of proteinase inhibitors in clinical practice. Pharmacotherapy 1994 ; 14 : 21S-9S.
69. Ankel H, Capobianco MR, Castilleti C, Dianzani F. Interferon induction by HIV glycoprotein 120 : role of the V3 loop. Virology 1994 ; 205 : 34-43.
70. Meylan PRA, Guatelli JC, Munis JR, Richman DD, Kornbluth RS. Mechanisms for the inhibition of HIV replication by interferons α β and γ in primary human macrophages. Virology 1993 ; 193 : 138-48.
71. Shirazi Y, Pitha P Interferon-α-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993 ; 193 : 303-12.
72. Coccia EM, Krust B, Hovanessian AC. Specific inhibition of viral protein synthesis in HIV-infecied cells in response to interferon treatment. J Biol Chem 1994 ; 269 : 23087-94.
73. + T-cell lines by distinct mechanisms : evidence for decreased stability and aberrant processing of HIV-1 proteins. Virology 1995 ; 214 : 379-86.
74. Vieillard V, Lauret E, Maguer V, et al. Autocrine interferon-β synthesis for gene therapy of HIV infection : increased resistance to HIV1 in lymphocytes from healthy and HIV-intected individuals. AIDS 1995 ; 9 : 1221-8.
75. Shirazi Y, Popick W, Pitha PM. Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by tat. J IFN Res 1993 ; 14 : 259-63.
76. Von Wussow P, Jakschies D, Block B, et al. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS 1990 ; 4 : 119-24.
77. Baca LM, Gems P, Kalvakolanu D, et al. Regulation of interferon-α-inducible cellular genes in human immunodeficiency virus-infected monocytes. J Leukocyte Biol 1994 ; 55 : 299-309.
78. Kelve HCM, Muller WE. The 2-5A system and HIV infection. [Review]. Progress in Molecular & Subcellular Biology 1994 ; 14 : 176-97.
79. Schröder HC, Suhadolnik RJ, Pfleiderer W, Charubala R, Muller WE. (2′-5′) oligoadenylate and intracellular immunity against retrovirus infection. [Review]. Int J Biochem 1992 ; 24 : 55-63
80. Mac Millan NAJ, Chun RF, Siderovski DP. et al. HIV-1 Tat RNA directly interacts with the interferon-induced. double-stranded RNA-dependent kinase PKR. Virology 1995 ; 213 : 413-24.
81. Bertoletti A, Ferrari C, Fiaccadori F, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Arad Sci USA 1991 ; 88 : 10445-8.
82. Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. Curr Topics Microbiol Immunol 1991 ; 168 : 21-39.
83. Guidotti LG, Guillot S, Chisari FV. Interleukin-2 and alpha, beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol 1994 ; 68 : 1265-70.
84. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996 ; 23 : 17-23.
85. Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alphainterferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B : a meta-analysis. Ann Intern Med 1993 ; 119 : 312-23.
86. Schuitz U, Kock J, Schlicht HJ, Staeheli P. Recombinant duck interferon : a new reagent for studying the mode of interferon action against hepatitis B virus. Virology 1995 ; 212 : 641-9.
87. Simmonds P. Variability of hepatitis C virus. Hepatology 1995 ; 21 : 570-83.
88. Maddrey WC. Chronic viral hepatitis : diagnosis and management. Hospital Practice 1994 ; 15 : 117-32.
89. Pawlotsky JM, Hovanessian AG. Roudot-Thoraval F. et al. Activity of the interferon-induced 2′-5′-oligoadenylate synthetase in patients with chronic hepatits C. J IFN Res 1995 ; 15 : 857-62.
90. Enomoto N, Sakuma I, Asahina Y, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatits C virus 1b : Sensitivity to interferon is conferred by aminoacid substitution in the NS5A region. J Clin Invest 1995 ; 96 : 224-30.
91. Gale MJ, Korth MJ, Tang NM, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997 ; 230 : 217-27.
92. Khorsi H, Castelain S, Wyseur A, et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 1997 ; 27 : 72-7.
93. Rogers RP, Strominger JL, Speck SH. Epstein-Barr virus in B lymphocytes : viral gene expression and function in latency (Review). Adv Cancer Res 1992 ; 58 : 1-26.
94. Schwemmle M, Clemens MJ, Hilse K, et al. Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymptioma cells. Proc Natl Acad Sci 1992 ; 89 : 10292-6.
95. Mathews MB, Shenk T Adenovirus virus-associated RNA and translation control. (Review). J Virol 1991 ; 65 : 5657-62.
96. Kedes DH, Operaskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) : distribution of infection in KS risk groups and evidence for sexual transmission. Nature Medecine 1996 ; 8 : 918-24.
97. Renne R, Lagunoff M, Zhong W, Ganem D. The size and conformation of Kaposi's sarcoma-associated Herpesvirus (Human Herpesvirus S) DNA in intected cells and virions. J Virol 1996 ; 70 : 8151-4.
98. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency type 1 tat protein. Proc Natl Acad Sci 1995 ; 92 : 4838-42.
99. Lilenbaum RC, Ratner L. Systemic treatment of Kaposi's sarcoma : current status and future directions. AIDS 1994 ; 8 : 141-51.